Moderna, BioNTech Leads Covid Sell-Off After Pfizer Slashes Outlook - Investor's Business Daily
- Moderna, BioNTech Leads Covid Sell-Off After Pfizer Slashes Outlook Investor's Business Daily
- Pfizer cuts guidance on slumping COVID vaccine, treatment sales Yahoo Finance
- Pfizer's COVID outlook cuts hit other vaccine maker shares Yahoo Finance
- Pfizer's earnings cut was 'sort of telegraphed', says E Squared's Les Funtleyder CNBC Television
- Pfizer Stock: Brutal End To COVID Gravy Train (NYSE:PFE) Seeking Alpha
- View Full Coverage on Google News